Investigating Cerebellar Inhibition and Its Clinical Significance in Parkinsonian Tremor and Intention Tremor Trial N/A Unknown Aug. 22, 2022
Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients Trial Early Phase 1 Completed Aug. 18, 2022
Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuseĀ® Delivery System in Parkinson's Disease Patients Trial Phase 2 Completed Aug. 9, 2022
NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's Disease Trial N/A Completed Aug. 8, 2022
Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System Trial N/A Recruiting Aug. 8, 2022
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients Trial Phase 2 Completed Aug. 7, 2022
Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients Trial Phase 2 Unknown Aug. 7, 2022
Group Versus Individuals Telehealth Exercise Programs for People With Parkinson Disease Trial N/A Completed Aug. 2, 2022
Motor-cognitive Dual-task in Healthy Older Adults and Early Parkinson's Disease Patients Trial N/A Unknown July 31, 2022
OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001 Trial Phase 2 Completed July 31, 2022
Symptomatic Relief of Action Tremor With Cala Trio Using Trio+ Bands Trial N/A Completed July 28, 2022
Physiological Benefits of High-intensity Interval Training for Individuals With Parkinson's Disease Trial N/A Completed July 27, 2022
Supplementary Motor Area is a Potential Target for Speech Disturbance in Parkinson Disease Trial N/A Unknown July 27, 2022